Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolol ratiopharm) forðatafla 95 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 95 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 100 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 100 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
metoprolol alvogen (metoprolol ratiopharm) forðatafla 190 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 190 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 95 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 95 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 47,5 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 47,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 23,75 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 23,75 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seloken zoc forðatafla 190 mg
recordati ireland limited* - metoprololum súkkínat - forðatafla - 190 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 25 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 25 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
bloxazoc forðatafla 200 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 200 mg